Maglasang, Ronel T.
HRN: 23-95-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/28/2023
11/04/2023
PO
7ml
Tid
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes